Form 4 for MGNX MACROGENICS INC
Accepted 2024-02-02 00:00:00 ET · period of report 2024-02-01 · accession 0001125345-24-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-02 | 2024-02-01 | MGNX | Bonvini Ezio | SVP, CSO, Research | S - Sale | $15.00 | -13.3K | 74.7K | -15% | -$199.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-01 | S | D | 13,316 | $15.00 | 74,668 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 17, 2023. |